Skip to main content
DC 7719Hematologic & Lymphatic System38 CFR § 4.117

Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)

VA disability rating criteria for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) under Diagnostic Code 7719. The VA assigns ratings of 30%, 60%, 100% based on the severity and functional impact of your condition.

Rating Criteria

30%Disability Rating

In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors

60%Disability Rating

Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission

100%Disability Rating

Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment

Get a Personalized Rating Analysis

AIDEN can analyze your specific symptoms, identify secondary connections, and help you understand what rating you may qualify for based on your medical evidence.

Talk to AIDEN